Early Retirement Portfolio: Top 15 Stocks to Buy

In this article, we will take a look at the Early Retirement Portfolio: Top 15 Stocks to Buy. 

On April 2, CNBC reported that while stocks often provide strong long-term growth despite short-term swings, a prolonged market downturn close to retirement can create real challenges.

If investors need to draw from their portfolios when prices are low, it can reduce how long their savings last. Mike Casey, founder and president of AE Advisors, explained that this can have lasting effects on retirement outcomes. This happens “by forcing investors to sell depressed assets and reducing the capital base available for recovery,” Casey said.

The issue is known as the sequence of returns risk. It refers to how the timing of gains and losses can affect a portfolio, especially when withdrawals begin. For long-term investors, the impact is usually less severe. Those who are still years or decades away from retirement have more time to recover from market declines before relying on their investments for income.

Frank Maltais of Fidelity Investments noted that for these investors, “the sequence of returns risk isn’t such a big deal.” He further made the following comment:

“If you retire into a poor market, that can diminish your nest egg over time, especially if you don’t scale down your withdrawals during that declining market. On the other hand, if you have a strong market early in retirement, that can really put the wind at your back.”

Given this, we will take a look at the best stocks for a retirement stock portfolio.

Photo by Ovidiu Gruescu on Unsplash

Our Methodology:

We employed a screener to select dividend stocks for this list that are suitable for a retirement stock portfolio, as they are diversified across multiple industries and have demonstrated robust and consistent payout policies. The stocks are ranked according to hedge funds having stakes in them as per Insider Monkey’s Q4 2025. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

15. Emerson Electric Co. (NYSE:EMR)

Number of Hedge Fund Holders: 42

On April 1, Wells Fargo analyst Joseph O’Dea lowered the firm’s price recommendation on Emerson Electric Co. (NYSE:EMR) to $135 from $160. It reiterated an Equal Weight rating on the shares. He noted that the Middle East conflict did not lead to a noticeable increase in caution during most of the firm’s catch-up calls. Still, he pointed out a familiar pattern. Last year, tariffs held back a recovery in PMI. Now, Wells sees a similar risk, where a new layer of uncertainty could weigh on sentiment until there is a clearer direction.

On March 31, Jefferies analyst Stephen Volkmann upgraded Emerson to Buy from Hold and raised the price target to $175 from $160 after taking over coverage of the stock. The firm said the company’s “strong” order momentum is expected to drive faster earnings growth. It sees growth moving from low single-digits in the first half of the year to low-double-digits by the time fiscal 2026 ends. The analyst also pointed to improving margins, noting that this trend should support higher valuation multiples, as stated in the research note.

Emerson Electric Co. (NYSE:EMR) operates as a global technology and software company. It provides solutions across a wide range of end markets worldwide. The business is structured into seven segments, grouped under two main divisions: Intelligent Devices and Software and Control.

14. Pentair plc (NYSE:PNR)

Number of Hedge Fund Holders: 48

On April 14, Stifel lowered the firm’s price recommendation on Pentair plc (NYSE:PNR) to $110 from $126. It maintained a Buy rating on the shares. The firm said Q1 earnings season is likely to “provide few surprises or guidance changes to act as catalysts” for its flow control and multi-industry coverage. That view came as part of its preview for the group.

On April 13, Citi also lowered its price goal on Pentair, bringing it down to $112 from $120, while maintaining a Buy rating. The adjustment was part of a broader Q1 preview across the industrials group. Citi said “gradually improving” industrial trends are still in place and should support solid Q1 earnings for most names in the sector.

During its Q4 2025 earnings call, Pentair shared its outlook for 2026. The company expects adjusted EPS to fall in the range of $5.25 to $5.40, which points to an increase of about 8% at the midpoint. It also expects overall sales to grow around 3% to 4%, with adjusted operating income rising between 5% and 8%.

Looking at the segments, the company expects Flow sales to grow at a mid- to high-single-digit pace. Water Solutions sales are likely to stay flat overall, though core growth is projected in the low single digits. Pool sales are expected to rise by about 3%. For the near term, Pentair expects Q1 2026 sales to grow roughly 1% to 2%. Adjusted EPS for the quarter is projected between $1.15 and $1.18, reflecting growth of around 4% to 6%. The company also outlined costs and external factors. It is targeting about $70 million in transformation savings in 2026, net of investments. At the same time, tariffs are expected to create an incremental headwind of around $30 million for the year, with most of the impact in the first quarter. Pentair plans to offset this through pricing actions and other mitigation efforts.

Pentair plc (NYSE:PNR) provides a broad range of smart and sustainable water solutions for homes, businesses, and industries worldwide. The company operates through three segments: Flow, Water Solutions, and Pool.

13. Dover Corporation (NYSE:DOV)

Number of Hedge Fund Holders: 49

On April 13, Citi analyst Andrew Kaplowitz raised the firm’s price recommendation on Dover Corporation (NYSE:DOV) to $253 from $231. It reiterated a Buy rating on the shares. The change came as part of a broader Q1 preview across the industrials group. Citi said “gradually improving” industrial trends are still holding up and should support solid Q1 earnings for most companies in the sector.

During the Q4 2025 earnings call, management shared its outlook for 2026. It expects adjusted EPS to be in the range of $10.45 to $10.65.This guidance reflects double-digit growth at the midpoint and is in line with the company’s long-term trajectory.

Richard Tobin, President, CEO & Chairman, also pointed to steady demand trends across the business. He said the order book remains healthy, and based on current visibility, no single end market is expected to create a meaningful headwind. He added that Clean Energy and Fueling is likely to play a key role in margin expansion in 2026. At the same time, Climate and Sustainability Technology is expected to continue growing at a double-digit pace.

Dover Corporation (NYSE:DOV) operates as a diversified global manufacturer and solutions provider. Its Engineered Products segment offers equipment, components, software, solutions, and services to markets such as the vehicle aftermarket, aerospace and defense, among others.

12. Chubb Limited (NYSE:CB)

Number of Hedge Fund Holders: 56

On April 14, BofA lowered the firm’s price recommendation on Chubb Limited (NYSE:CB) to $271 from $286. It reiterated an Underperform rating on the shares. The firm made the adjustment across its U.S. insurance coverage, reflecting Q4 events and changes in peer multiples.

On April 8, Barclays moved in the opposite direction, raising its price target on Chubb to $374 from $339 while maintaining an Equal Weight rating. The update came as part of its Q1 preview for the insurance group. The analyst said premium growth and broker organic growth “are likely to remain sluggish,” according to a research note. Barclays still expects solid margins and strong capital deployment to support reported book value growth in Q1.

Chubb Limited (NYSE:CB) is a Switzerland-based holding company. Through its subsidiaries, the company provides a range of insurance and reinsurance products and services to clients worldwide.

11. Colgate-Palmolive Company (NYSE:CL)

Number of Hedge Fund Holders: 62

On April 14, Barclays analyst Lauren Lieberman lowered the firm’s price recommendation on Colgate-Palmolive Company (NYSE:CL) to $79 from $88. It reiterated an Equal Weight rating on the shares. The change came as part of a broader Q1 preview across the consumer staples group. Barclays said it has “growing caution” heading into earnings, pointing to higher input costs. In food, the analyst noted there are now “building concerns” around the sustainability of the dividend for certain companies, according to a research note.

On April 10, BofA analyst Peter Galbo also trimmed the price target on Colgate-Palmolive, bringing it down to $102 from $105, while maintaining a Buy rating. Ahead of Q1 earnings, the firm updated its estimates for organic sales and FY26 EPS. The revisions reflect several factors, including a shift in the launch timing of Optic White in North America, which is affecting consumption. The analyst also incorporated a more conservative view on gross margins, taking into account the potential impact from rising oil costs, as noted in the preview.

Colgate-Palmolive Company (NYSE:CL) operates across Oral Care, Personal Care, Home Care, and Pet Nutrition. Its Oral, Personal, and Home Care business spans North America, Latin America, Europe, Asia Pacific, and Africa/Eurasia, serving retailers, distributors, dentists, and skin health professionals.

10. Medtronic plc (NYSE:MDT)

Number of Hedge Fund Holders: 63

On April 13, Mizuho lowered the firm’s price recommendation on Medtronic plc (NYSE:MDT) to $120 from $125. It kept an Outperform rating on the shares. The firm made the adjustment as it updated estimates and price targets across several names in its medical devices and diagnostics coverage ahead of Q1 earnings.

On April 7, Citi analyst Joanne Wuensch also lowered the price target on Medtronic to $110 from $117, while maintaining a Buy rating. The changes were part of a broader Q1 preview for the medical technology group. The analyst said the “walls of worry are high” heading into earnings, with the sector seeing significant multiple compression, according to a research note. Citi also removed iRhythm and Medtronic as top picks, naming Edwards Lifesciences and Intuitive Surgical as its new top choices.

Medtronic plc (NYSE:MDT) is based in Ireland and provides healthcare technology solutions. Its products are organized across four main segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes.

9. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 84

On April 13, Evercore ISI lowered its price recommendation on AbbVie Inc. (NYSE:ABBV) to $232 from $233. It reiterated an Outperform rating on the shares. The adjustment came as the analyst updated estimates in a Q1 preview note.

A few days earlier, on April 6, AbbVie issued a preliminary financial update, lowering its earnings expectations for both the first quarter and the full year of 2026. The revision was driven by $744 million in pre-tax expenses tied to acquired in-process research and development (IPR&D) and milestone payments recorded in the first quarter. This charge reduced earnings by $0.41 per share on both a GAAP and adjusted non-GAAP basis.

With these changes, the company now expects full-year 2026 adjusted diluted EPS to be in the range of $13.96 to $14.16, compared with the consensus estimate of $14.52 and prior guidance of $14.37 to $14.57. For the first quarter, guidance is set at $2.56 to $2.60, versus the consensus of $2.99 and earlier guidance of $2.97 to $3.01.

AbbVie Inc. (NYSE:ABBV) is a global, diversified research-based biopharmaceutical company. It is involved in the research and development, manufacturing, commercialization, and sale of medicines and therapies across areas such as Immunology, Oncology, Aesthetics, Neuroscience, Eye Care, and other key products.

8. Caterpillar Inc. (NYSE:CAT)

Number of Hedge Fund Holders: 86

On April 13, Citi analyst Kyle Menges raised the firm’s price recommendation on Caterpillar Inc. (NYSE:CAT) to $905 from $785. It maintained a Buy rating on the shares. The update came as part of the firm’s Q1 preview for the machinery group. He pointed out that the North American truck market has improved over the past few months. Citi continues to lean toward companies with stronger exposure to construction rather than agriculture, according to the note shared with investors.

On April 9, Chad Dillard of Bernstein raised the price target on Caterpillar to $769 from $678 while keeping a Market Perform rating ahead of quarterly results. The firm noted that most forward-looking indicators suggest demand is starting to pick up again. It also said expectations already reflect a slower start to 2026. Still, Bernstein flagged some uncertainty around the broader economic outlook. The firm added that, from a tactical standpoint, it prefers companies with meaningful exposure to long-term secular markets that can sustain growth even if cyclical conditions remain uneven.

Caterpillar Inc. (NYSE:CAT) operates as a manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. Its business is organized into Construction Industries, Resource Industries, and Power & Energy segments. The company also offers financing and related services through its Financial Products division.

7. Chevron Corporation (NYSE:CVX)

Number of Hedge Fund Holders: 86

On April 13, RBC Capital raised the firm’s price recommendation on Chevron Corporation (NYSE:CVX) to $220 from $200. It reiterated an Outperform rating on the shares. The firm said the updated target reflects its revised commodity price outlook, as noted in a research report. It also pointed out that Chevron, like its peers, has already shared some early guidance ahead of the quarter. That update flagged similar trends seen across the sector, including notable timing-related headwinds and several upstream outages, which are expected to weigh on volumes sequentially.

On April 13, Reuters reported that Chevron signed two key agreements to expand operations in Venezuela’s Orinoco Belt. The deals include an asset swap that adds an extra heavy crude area to its main project while returning an offshore gas field and a smaller crude asset, according to executives and officials speaking at the event. These agreements are among the first major expansion moves following a $100 billion reconstruction plan for Venezuela’s energy sector and recent reforms to the country’s oil law aimed at attracting foreign investment.

Chevron signed new agreements with Venezuela’s state oil company, PDVSA, to expand its role in the country’s primary oil-producing region. As part of the deal, the company increased its stake in the Petroindependencia joint venture from 35.8% to 49%, strengthening its position in heavy oil production. In return, Chevron gave up certain assets, including two gas blocks, one of which contains the Loran offshore field, along with a smaller oil project. It received a new oil area, Ayacucho 8, which will be integrated into its existing Petropiar project.

The agreement allows Chevron to concentrate on its core oil assets, deepen its partnership with PDVSA, and expand its footprint in Venezuela’s heavy oil sector, where competition from other international players is expected to increase.

Chevron Corporation (NYSE:CVX) operates as an integrated energy company. It produces crude oil and natural gas, and also manufactures transportation fuels, lubricants, petrochemicals, and additives. The company is organized into two main segments, Upstream and Downstream, and also focuses on developing technologies that support its operations and the broader energy industry.

6. The Coca-Cola Company (NYSE:KO)

Number of Hedge Fund Holders: 87

On April 7, UBS raised the firm’s price recommendation on The Coca-Cola Company (NYSE:KO) to $90 from $87. It maintained a Buy rating on the shares. The firm said Q1 results across much of the consumer staples group are expected to be “okay.” It sees organic revenue growth showing signs of improvement and some stabilization. At the same time, the focus is shifting to forward-looking commentary. Inflation remains a concern, especially for the second half of the year and possibly beyond, according to the analyst’s preview note.

On April 1, Reuters reported that Coca-Cola, along with its authorized bottlers Coca-Cola Beverages South Africa and Coca-Cola Peninsula Beverages, plans to invest 17.6 billion rand ($1.05 billion) in South Africa through 2030. The announcement came from Luis Felipe Avellar, president of the Coca-Cola Company’s Africa operating ​unit, during an investment conference in Johannesburg. At the same event, Cyril Ramaphosa outlined a goal of attracting 2 trillion rand in new investments over the next five years.

The company said the investment will expand production capacity, strengthen distribution, and support innovation across the Coca-Cola system’s value chain in the region.

The Coca-Cola Company (NYSE:KO) operates as a global beverage business with reporting segments that include Europe, the Middle East and Africa, Latin America, North America, Asia Pacific, and Bottling Investments. Its portfolio includes well-known sparkling soft drinks such as Coca-Cola, Sprite, and Fanta, along with a broader range of beverages sold worldwide.

Click to continue reading and see the Early Retirement Portfolio: Top 5 Stocks to Buy

Disclosure: None. Follow Insider Monkey on Google News.